Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve 1. To consider, approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Drugs & Industries has informed BSE that its Board of Directors will meet on Saturday, 07 February 2026. The key item on the agenda is to consider and approve the Unaudited Financial Results of the Company for the quarter ended 31st December 2025 (Q3 FY26). Any other business with the Chair's permission may also be discussed. The trading window for designated persons has been closed from 1st January 2026 until 48 hours after the results are announced, in line with insider trading regulations.
This is a routine pre-results intimation with no actual financial numbers disclosed yet. Shareholders should watch the announcement on 07 February 2026 for the actual Q3 FY26 performance, which could move the stock depending on how results compare to expectations.